4//SEC Filing
WG Biotech ApS 4
Accession 0001104659-21-079610
CIK 0001722964other
Filed
Jun 9, 8:00 PM ET
Accepted
Jun 10, 7:00 PM ET
Size
7.8 KB
Accession
0001104659-21-079610
Insider Transaction Report
Form 4
WG Biotech ApS
Director10% Owner
Transactions
- Sale
Common Stock
2021-06-08$35.28/sh−33,300$1,174,694→ 4,306,394 total - Sale
Common Stock
2021-06-09$36.19/sh−116,700$4,223,116→ 4,189,694 total
Footnotes (2)
- [F1]This transaction was executed in multiple trades at prices ranging from $34.50 to $35.85. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]This transaction was executed in multiple trades at prices ranging from $35.785 to $36.35. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
Y-mAbs Therapeutics, Inc.
CIK 0001722964
Entity typeother
IncorporatedDenmark
Related Parties
1- filerCIK 0001753193
Filing Metadata
- Form type
- 4
- Filed
- Jun 9, 8:00 PM ET
- Accepted
- Jun 10, 7:00 PM ET
- Size
- 7.8 KB